Clinical Trial Update: OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of OTX-DP for post-surgical ocular pain and inflammation after cataract surgery completed with results posted in October 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-surgical Ocular Inflammation
• Post-surgical Ocular Pain

Drugs mentioned

• OTX-DP

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Post-Surgical Ocular Pain, Post-Surgical Ocular Inflammation | Phase 3 | Status: COMPLETED | Results posted: 2017-10-11